Search all trials

Find therapies in clinical trials near you – page 36

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Plasma cell leukaemia

Not recruiting

Registered drugNo placebo

Study on Daratumumab, Lenalidomide, and Dexamethasone for Patients with Primary Plasma Cell Leukemia

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

Investigational

Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

Investigational

France

Participants:18–64 years · 65+ years
Substances:Enasidenib Mesilate

Contact Research Centre

Depression

Not recruiting

Registered drugNo placebo

Study of nitrous oxide and medical air inhalation in elderly patients with treatment-resistant depression

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Nitrogen

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drug

Study of Ivosidenib and Azacitidine for Patients Aged 18 and Older with Untreated Acute Myeloid Leukemia with IDH1 Mutation

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Myelofibrosis+1

Not recruiting

Registered drugNo placebo

Study of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Danazol

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study of Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Registered drugNo placebo

France

Participants:65+ years
Substances:Bortezomib

Contact Research Centre

Phenylketonuria

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety of PTC923 (Sepiapterin) for Patients with Phenylketonuria

InvestigationalNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:(S)-2-Amino-6-(2-Hydroxypropanoyl)-7,8-Dihydropteridin-4(3H)-One

Contact Research Centre

B-cell lymphoma refractory

Not recruiting

Registered drugNo placebo

Study of Epcoritamab for Patients with Relapsed, Progressive, or Refractory B-Cell Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Anakinra

Contact Research Centre

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Anakinra

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study of Elranatamab, Dexamethasone, and Diphenhydramine Hydrochloride for Patients with High-Risk Smoldering Multiple Myeloma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Dexamethasone

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Talquetamab, Pomalidomide, and Teclistamab for Patients with Relapsed or Refractory Myeloma After 1 to 4 Prior Treatments

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Study on Luspatercept for Patients with Lower-risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Not recruiting

Registered drugNo placebo

Study on Luspatercept for Patients with Lower-risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Luspatercept

Contact Research Centre

Find therapies in clinical trials near you – page 36

537 trials match your criteria

Plasma cell leukaemia

Study on Daratumumab, Lenalidomide, and Dexamethasone for Patients with Primary Plasma Cell Leukemia

Acute myeloid leukaemia+1

Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

Depression

Study of nitrous oxide and medical air inhalation in elderly patients with treatment-resistant depression

Acute myeloid leukaemia

Study of Ivosidenib and Azacitidine for Patients Aged 18 and Older with Untreated Acute Myeloid Leukemia with IDH1 Mutation

Myelofibrosis+1

Study of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors

Plasma cell myeloma

Study of Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Phenylketonuria

Study on the Long-Term Safety of PTC923 (Sepiapterin) for Patients with Phenylketonuria

B-cell lymphoma refractory

Study of Epcoritamab for Patients with Relapsed, Progressive, or Refractory B-Cell Lymphoma

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Plasma cell myeloma

Study of Elranatamab, Dexamethasone, and Diphenhydramine Hydrochloride for Patients with High-Risk Smoldering Multiple Myeloma

Plasma cell myeloma

Study Comparing Talquetamab, Pomalidomide, and Teclistamab for Patients with Relapsed or Refractory Myeloma After 1 to 4 Prior Treatments

Study on Luspatercept for Patients with Lower-risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Study on Luspatercept for Patients with Lower-risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.